The Top Five Product Searches on CPHI Online: December
Which were the products that drew the most interest in the CPHI directory in December? We analyse search data from the CPHI directory…
1. Avoquin 4% - Avalon Pharma
Retaining its position at the top of the tree during the previous month, this skin lightening cream continues to attract the most interest on CPHI Online.
The formulation – sold in African, Middle Eastern and Asian markets -- contains hydroquinone, which the company describes as the ‘gold standard’ for treatment of skin hyperpigmentation and claims has been proven in clinical trials to be the safest and most effective skin lightening agent.
Skin lightening refers to the practice of using chemical substances to lighten the skin or provide an even skin colour by reducing the melanin concentration. Hydroquinone is currently not approved for this purpose in Europe.
2. Avocom-M cream – Avalon Pharma
This anti-inflammatory, antipruritic and anti-allergic cream, also from Avalon Pharma, crept up one place in December. The product is a unique combination of corticosteroid, Mometasone Furoate, (0.1% concentration) and anti-fungal Miconazole Nitrate (2%).
3. Avalon Avotin -Avalon Pharma
Last month, Avalon recorded three products in the top five; this month the young Saudi Arabian company has matched that, with the added bonus of them occupying all three podium positions. This formulation of Tretinoin cream, a derivative of vitamin A, was a new entry in December. It is a versatile retinoid that works by increasing the growth rate of skin cells and is used to treat a variety of skin conditions, from acne to aging.
4. Spasmo-Apotel (Paracetamol + Hyoscine Butylbromide) – Uni-Pharma
The month’s second new entrant comes from Greece’s Uni-Pharma and is a combination of hyoscine hydrobromide, taken to relieve stomach cramps, including those linked with irritable bowel syndrome, and painkiller, paracetamol.
5. Mycoten - Munir Sukhtian Group
Rounding off, the top five, this antifungal treatment slipped down three places from second position in November. The formulation, available in both tablets and cream, contains the active ingredient clotrimazole and is used for the relief of vaginal itching, burning, and discharge associated with vaginal yeast infections (vulvovaginal candidiasis).
Related News
-
News Bringing the pharmaceutical supply chain closer to home
The pharmaceutical supply chain has encountered numerous disruptions in the last few years, impacting procurement, manufacturing, packaging, and distribution operations within the pharmaceutical industry. Read about the rise in calls for near/resh... -
News Women in Pharma: Advancing gender diversity & healthcare equality
In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News Humira biosimilars at discounted prices to meet market demand for accessible treatment
Several biosimilars to AbbVie’s monoclonal antibody therapeutic Humira were launched by various pharmaceutical giants this week in the US, with more expected to be released by the end of the year as the patent expires. -
News Women in Pharma: Gearing up for systemic change
In our new monthly series, we interview women from across the pharmaceutical industry and supply chain to discuss the importance of gender diversity in healthcare, the workplace, and beyond. -
News Delivering on mRNA-based therapeutics: innovations in applications and packaging
Since the onset of the COVID-19 pandemic, the innovative potential of mRNA vaccines and therapeutics has raised questions regarding their manufacturing, packaging, and storage/transportation. Learn about how the pharmaceutical supply chain is meet... -
News Novavax will provide adjuvant Matrix-M for vaccine research with 3-year partnership
Novavax, developers behind the Matrix-M adjuvant, have entered into an agreement with the Bill and Melinda Gates Medical Research Institute to provide the adjuvant in preclinical vaccine research. -
News CPHI Online Webinar Series – The CPO Perspective: Driving Healthcare Sustainability
Pharmaceutical contract packaging organisations (CPOs) offer organisations broader expertise in pharma packaging, specialist skills, and flexibility with time, efficiency, and costings for pharmaceutical companies lacking in-house packaging expert... -
News The CPO Starter Pack: Why and When to Bring in a Contract Packaging Partner
Discover the trends affecting the pharmaceutical CPO market, when and why outsourcing may be an enticing option, and what is driving pharmaceutical companies and CDMOs to partner with outsourced packaging and drug delivery organisations. ...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance